Mary Catherine Beach1, Debra L Roter2, Somnath Saha3, P Todd Korthuis4, Susan Eggly5, Jonathan Cohn5, Victoria Sharp, Richard D Moore2, Ira B Wilson6. 1. Berman Institute of Bioethics, Johns Hopkins University, Baltimore, USA; Department of Medicine, Johns Hopkins School of Medicine, Baltimore, USA; Department of Health, Behavior & Society, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA; Welch Center for Prevention, Epidemiology and Clinical Research, USA. Electronic address: mcbeach@jhmi.edu. 2. Department of Medicine, Johns Hopkins School of Medicine, Baltimore, USA; Department of Health, Behavior & Society, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA. 3. Portland VA Medical Center, Portland, USA; Department of Medicine, Oregon Health Sciences University, Portland, USA. 4. Department of Medicine, Oregon Health Sciences University, Portland, USA. 5. Department of Medicine, Wayne State University, Detroit, USA. 6. Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, USA.
Abstract
INTRODUCTION: Medication adherence is essential in HIV care, yet provider communication about adherence is often suboptimal. We designed this study to improve patient-provider communication about HIV medication adherence. METHODS: We randomized 26 providers at three HIV care sites toreceive or not receive a one-hour communication skills training based on motivational interviewing principles applied to medication adherence. Prior to routine office visits, non-adherent patients of providers who received the training were coached to discuss adherence with their providers. Patients of providers who did not receive the training providers were not coached. We audio-recorded and coded patient-provider interactions using the roter interaction analysis system (RIAS). RESULTS: There was more dialogue about therapeutic regimen in visits with intervention patients and providers (167 vs 128, respectively, p=.004), with the majority of statements coming from providers. These visits also included more brainstorming solutions to nonadherence (41% vs. 22%, p=0.026). Intervention compared with control visit providers engaged in more positive talk (44 vs. 38 statements, p=0.039), emotional talk (26 vs. 18 statements, p<0.001), and probing of patient opinion (3 vs. 2 statements, p=0.009). CONCLUSION: A brief provider training combined with patient coaching sessions, improved provider communication behaviors and increased dialogue regarding medication adherence.
RCT Entities:
INTRODUCTION: Medication adherence is essential in HIV care, yet provider communication about adherence is often suboptimal. We designed this study to improve patient-provider communication about HIV medication adherence. METHODS: We randomized 26 providers at three HIV care sites to receive or not receive a one-hour communication skills training based on motivational interviewing principles applied to medication adherence. Prior to routine office visits, non-adherent patients of providers who received the training were coached to discuss adherence with their providers. Patients of providers who did not receive the training providers were not coached. We audio-recorded and coded patient-provider interactions using the roter interaction analysis system (RIAS). RESULTS: There was more dialogue about therapeutic regimen in visits with intervention patients and providers (167 vs 128, respectively, p=.004), with the majority of statements coming from providers. These visits also included more brainstorming solutions to nonadherence (41% vs. 22%, p=0.026). Intervention compared with control visit providers engaged in more positive talk (44 vs. 38 statements, p=0.039), emotional talk (26 vs. 18 statements, p<0.001), and probing of patient opinion (3 vs. 2 statements, p=0.009). CONCLUSION: A brief provider training combined with patientcoaching sessions, improved provider communication behaviors and increased dialogue regarding medication adherence.
Authors: Mary Catherine Beach; Somnath Saha; P Todd Korthuis; Victoria Sharp; Jonathon Cohn; Ira Wilson; Susan Eggly; Lisa A Cooper; Debra Roter; Andrea Sankar; Richard Moore Journal: J Gen Intern Med Date: 2010-03-18 Impact factor: 5.128
Authors: Somnath Saha; David S Sanders; Philip Todd Korthuis; Jonathan A Cohn; Victoria L Sharp; Paul Haidet; Richard D Moore; Mary Catherine Beach Journal: Patient Educ Couns Date: 2011-02-18
Authors: Mary Catherine Beach; Somnath Saha; P Todd Korthuis; Victoria Sharp; Jonathon Cohn; Ira B Wilson; Susan Eggly; Lisa A Cooper; Debra Roter; Andrea Sankar; Richard Moore Journal: AIDS Behav Date: 2011-05
Authors: Ira B Wilson; Michael Barton Laws; Steven A Safren; Yoojin Lee; Minyi Lu; William Coady; Paul R Skolnik; William H Rogers Journal: J Acquir Immune Defic Syndr Date: 2010-03 Impact factor: 3.731
Authors: Tessie W October; Pamela S Hinds; Jichuan Wang; Zoelle B Dizon; Yao I Cheng; Debra L Roter Journal: Pediatr Crit Care Med Date: 2016-06 Impact factor: 3.624
Authors: Mary Hawk; Robert W S Coulter; James E Egan; Mackey Reuel Friedman; Steven Meanley; Stuart Fisk; Courtney Watson; Suzanne Kinsky Journal: AIDS Patient Care STDS Date: 2017-11-17 Impact factor: 5.078
Authors: David Córdova; Frania Mendoza Lua; Lauretta Ovadje; Kathryn Fessler; José A Bauermeister; Christopher P Salas-Wright; Michael G Vaughn; Youth Leadership Council Journal: Health Commun Date: 2017-07-07
Authors: Mary Catherine Beach; M Barton Laws; Gary Rose; Debra Roter; Yoojin Lee; Geetanjali Chander; Tanita Woodson; Richard D Moore; William Rogers; Ira B Wilson Journal: AIDS Behav Date: 2018-01
Authors: Thomas A D'Agostino; Thomas M Atkinson; Lauren E Latella; Madeline Rogers; Dana Morrissey; Antonio P DeRosa; Patricia A Parker Journal: Patient Educ Couns Date: 2017-02-16
Authors: Wynne Callon; Mary Catherine Beach; Somnath Saha; Geetanjali Chander; Ira B Wilson; Michael Barton Laws; Victoria Sharp; Jonathan Cohn; Richard Moore; P Todd Korthuis Journal: J Gen Intern Med Date: 2016-05-19 Impact factor: 5.128